Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

Janssen seeks approval for Velcade subcutaneous injection in Japan

Feb. 1, 2012

TGen and University of Arizona receive funding for cancer research

Feb. 1, 2012

Spectrum Pharmaceuticals in-licenses long-acting granulocyte colony-stimulating factor

Feb. 1, 2012

Novel DNA-dependent protein kinase inhibitors claimed by Merck KGaA

Feb. 1, 2012

Tyrosine-protein kinase SYK inhibitors may counter retinoblastoma

Feb. 1, 2012

FDA approves first treatment for advanced BCC

Jan. 31, 2012

Allos Therapeutics requests reexamination of CHMP opinion on Folotyn

Jan. 31, 2012

University of Illinois forms new start-up company for cancer products

Jan. 31, 2012

Novel protein kinase inhibitors disclosed by SBI Biotech and CrystalGenomics

Jan. 31, 2012

Overseas trials begin for Pro-Rvlysin prostate cancer treatment

Jan. 30, 2012

Popular Stories

Today's news in brief
BioWorld
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
Inhibiting the NLRP3 inflammasome for cognitive impairment, stroke
BioWorld Science
Vascular cognitive impairment and dementia (VCID) and cerebral small vessel disease are among the leading causes of dementia, where inflammation is known to play...
VST Bio’s VB-001 is neuroprotector after stroke
BioWorld Science
At the recent International Stroke Conference, researchers from VST Bio Corp. and Yale University presented preclinical data regarding VB-001, a monoclonal...